Oliver Lagore Vanvalin Investment Group’s Dow Inc DOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$19K Buy
+545
New +$15.9K 0.01% 350
2024
Q4
$22.3K Buy
555
+20
+4% +$933 0.01% 348
2024
Q3
$29.2K Sell
535
-500
-48% -$26.4K 0.01% 306
2024
Q2
$54.9K Buy
1,035
+710
+218% +$40.6K 0.02% 229
2024
Q1
$18.8K Sell
325
-150
-32% -$8.29K 0.01% 348
2023
Q4
$26K Sell
475
-268
-36% -$13.7K 0.01% 288
2023
Q3
$38.3K Sell
743
-2
-0.3% -$107 0.02% 271
2023
Q2
$39.7K Hold
745
0.01% 275
2023
Q1
$40.8K Hold
745
0.02% 210
2022
Q4
$37.5K Hold
745
0.02% 209
2022
Q3
$33K Sell
745
-50
-6% -$2.54K 0.02% 201
2022
Q2
$41K Buy
795
+380
+92% +$24.3K 0.02% 191
2022
Q1
$26K Buy
+415
New +$25K 0.02% 230

Other funds holding DOW

Oliver Lagore Vanvalin Investment Group's DOW Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Dow Inc (DOW) in Q2 2025: 545 shares worth $19K. The stake represents 0.01% of the portfolio and ranks #350 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in DOW as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in DOW in Q1 2022 and has held it in 13 quarters since. The position peaked at $54.9K in Q2 2024. 1,211 funds tracked by Wall St. Rank hold DOW as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 545 shares of Dow Inc worth $19K as of Q2 2025.
  • Dow Inc was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Dow Inc made up 0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #350 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Dow Inc in Q1 2022 and has held it in 13 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Dow Inc position peaked at $54.9K in Q2 2024.
  • 1,211 funds tracked by Wall St. Rank held Dow Inc as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.